Amgen
Decode Genetics Plasma Proteome Study Improves Understanding of Disease Pathogenesis
In a cohort of almost 36,000 Icelanders, the researchers found more than 18,000 associations between sequence variants and plasma protein levels.
Researchers described the variant, disease, drug target, and drug safety insights being gained analyzing more than 150,000 UK Biobank whole-genome sequences.
Vertigo Risk Variant Set Points to Related Inner Ear Processes
With a genome-wide association meta-analysis that included almost 943,000 vertigo cases or controls, researchers focused on vertigo-associated loci in inner ear-related genes.
Decode Study Identifies Proteomic Predictors of All-Cause Mortality
Using Somalogic's SomaScan to analyze nearly 23,000 subjects, the researchers identified signatures indicating high and low risks of death within 10 years.
FDA Approves Amgen's Lumakras for NSCLC Alongside Companion Tests From Guardant Health, Qiagen
The approval makes Lumakras the first inhibitor of KRAS, once considered "undruggable," to reach the market for KRAS-mutated NSCLC.